3
Announcements
Trials
Browse
Landscape
Status
Recruiting
2
Active not recruiting
2
Terminated
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Primary Myelofibrosis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
pembrolizumab
116
Carboplatin
46
Nivolumab
45
Paclitaxel
34
Cyclophosphamide
34
Cisplatin
32
Gemcitabine
30
atezolizumab
28
Specimen Handling
26
venetoclax
25
Magnetic Resonance Spectroscopy
24
Docetaxel
24
fludarabine
23
Pemetrexed
23
Biopsy
22
Bevacizumab
22
Radiotherapy
21
Ipilimumab
21
Azacitidine
21
Dexamethasone
19
durvalumab
18
Radiosurgery
18
Fluorouracil
17
Cetuximab
16
Trastuzumab
15
fludarabine phosphate
14
Leucovorin
14
Cytarabine
14
tislelizumab
13
Lenalidomide
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
luspatercept
×
1 year
×
Clear all
NCT01688011
2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
2,013 enrolled